Cargando…

Vitreous Inflammatory Cytokines and Chemokines, Not Altered After Preoperative Adjunctive Conbercept Injection, but Associated With Early Postoperative Macular Edema in Patients With Proliferative Diabetic Retinopathy

PURPOSE: To investigate the influence of preoperative adjunctive anti-VEGF drug (Conbercept) on vitreous inflammatory cytokines and chemokines profiles and whether those cytokines were associated with early macular edema (ME) after surgery for patients with proliferative diabetic retinopathy (PDR)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hongyan, Zou, Wenjun, Zhang, Zhengyu, Huang, Darui, Zhao, Jinxiang, Qin, Bing, Xie, Ping, Mugisha, Aime, Liu, Qinghuai, Hu, Zizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928061/ https://www.ncbi.nlm.nih.gov/pubmed/35309074 http://dx.doi.org/10.3389/fphys.2022.846003

Ejemplares similares

Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy
por: Li, Bing, et al.
Publicado: (2020)

Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
por: Dai, Ying, et al.
Publicado: (2014)

Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
por: Wei, Qingquan, et al.
Publicado: (2019)

Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy
por: Zhang, Yunda, et al.
Publicado: (2021)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018)

Conbercept and Retinal Photocoagulation in the treatment of Diabetic Macular Edema
por: Meng, Weizhe, et al.
Publicado: (2019)

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
por: Aljundi, Wissam, et al.
Publicado: (2022)

Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy
por: He, Feng, et al.
Publicado: (2020)

Association of vitreous vitamin C depletion with diabetic macular ischemia in proliferative diabetic retinopathy
por: Park, Sung Wook, et al.
Publicado: (2019)

Emerging Role of Exosomes in Retinal Diseases
por: Zhang, Zhengyu, et al.
Publicado: (2021)

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA
por: Ba, Teer, et al.
Publicado: (2020)

Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
por: Wang, Weiwei, et al.
Publicado: (2023)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema
por: Zhou, Qingyun, et al.
Publicado: (2019)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020)

Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012)

A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy
por: Yang, Xiaochun, et al.
Publicado: (2016)

Efficacy of intravitreal injection of conbercept on non-proliferative diabetic retinopathy: a retrospective study
por: Wang, Jing, et al.
Publicado: (2020)

The relationship between renal function and surgical outcomes of patients with proliferative diabetic retinopathy
por: Liu, Jin, et al.
Publicado: (2022)

Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
por: Shi, Lei, et al.
Publicado: (2012)

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
por: Mandava, Nikhil, et al.
Publicado: (2020)

Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
por: Loporchio, Dean F., et al.
Publicado: (2021)

EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
por: Sun, Zuhua, et al.
Publicado: (2017)

Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions
por: Ding, Xiaoxia, et al.
Publicado: (2022)

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection
por: Zou, Chen, et al.
Publicado: (2018)

Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
por: Xu, Wei, et al.
Publicado: (2019)

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2023)

Effect of Adjunctive Intravitreal Conbercept Injection at the End of 25G Vitrectomy on Severe Proliferative Diabetic Retinopathy: 6-Month Outcomes of a Randomised Controlled Trial
por: Li, Houshuo, et al.
Publicado: (2023)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
por: Lin, Albert L, et al.
Publicado: (2020)

Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment
por: Xu, Yupeng, et al.
Publicado: (2019)

Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema
por: Wang, Jing, et al.
Publicado: (2021)

Conbercept combined with laser photocoagulation in the treatment of diabetic macular edema and its influence on intraocular cytokines
por: Zhan, Hui-Qin, et al.
Publicado: (2023)

Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab
por: Xing, Peiyu, et al.
Publicado: (2023)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
por: Cui, Jinglin, et al.
Publicado: (2018)

Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy
por: Yang, Zhikun, et al.
Publicado: (2023)

The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study
por: Jiang, Tingting, et al.
Publicado: (2020)

Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema
por: Huang, Yikeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfhrnavfd5u0b1o3fer496tpkh